Tavio Capital’s Quest Diagnostics DGX Stock Holding History

Tavio Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-362,612	Closed	-$39.9M	–	19
2018 Q2	$39.9M	Buy	+362,612	New	+$37.8M	13.5%	1

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Tavio Capital's DGX Position: Q3 2018 in Review

Tavio Capital sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 362,612 shares — an estimated $39.9M sold.

Tavio Capital first reported a position in DGX in Q2 2018 and held it in 1 quarter. The position peaked at $39.9M in Q2 2018. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

Tavio Capital reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
Tavio Capital sold 362,612 Quest Diagnostics shares in Q3 2018, an estimated $39.9M.
Tavio Capital first reported a position in Quest Diagnostics in Q2 2018 and held it in 1 quarter.
Tavio Capital's Quest Diagnostics position peaked at $39.9M in Q2 2018.
673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Tavio Capital's 13F filing for Q3 2018, filed 13 Nov 2018.